Disc Medicine Director Kevin Bitterman Reports $3.35 Million Common Share Disposal

• Disc Medicine director Kevin Bitterman reported sales of 41,825 common shares held indirectly from Oct. 19-21, 2026.
• Reported sale prices were $79.97 on Oct. 19, $79.95 on Oct. 20, and $80.23 on Oct. 21.
• Indirect holdings totaled 602,698 common shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Disc Medicine Inc. i published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001591747-26-000009), on October 21, 2026, and is solely responsible for the information contained therein.